Send to

Choose Destination
Diabet Med. 2018 Aug;35(8):1018-1026. doi: 10.1111/dme.13676.

Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal Association.

Author information

Imperial College Healthcare NHS Trust, London, UK.
Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Iran.
Royal London Hospital, Whitechapel, London, UK.
Birmingham City Hospital (Sandwell and West Birmingham Hospitals NHS Trust), Birmingham, UK.
Derby Teaching Hospitals NHS Foundation Trust and University of Nottingham, UK.
East and North Herts NHS Trust, UK.
University Hospitals of Leicester NHS Trust, UK.
North Middlesex University Hospital NHS Trust, UK.
St James University Hospital, Leeds, UK.
Queen Elizabeth II Hospital, Welwyn Garden City, UK.


Diabetic nephropathy remains the principal cause of end-stage renal failure in the UK and its prevalence is set to increase. People with diabetes and end-stage renal failure on maintenance haemodialysis are highly vulnerable, with complex comorbidities, and are at high risk of adverse cardiovascular outcomes, the leading cause of mortality in this population. The management of people with diabetes receiving maintenance haemodialysis is shared between diabetes and renal specialist teams and the primary care team, with input from additional healthcare professionals providing foot care, dietary support and other aspects of multidisciplinary care. In this setting, one specialty may assume that key aspects of care are being provided elsewhere, which can lead to important components of care being overlooked. People with diabetes and end-stage renal failure require improved delivery of care to overcome organizational difficulties and barriers to communication between healthcare teams. No comprehensive guidance on the management of this population has previously been produced. These national guidelines, the first in this area, bring together in one document the disparate needs of people with diabetes on maintenance haemodialysis. The guidelines are based on the best available evidence, or on expert opinion where there is no clear evidence to inform practice. We aim to provide clear advice to clinicians caring for this vulnerable population and to encourage and improve education for clinicians and people with diabetes to promote empowerment and self-management.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center